NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
about
Imaging of brain dopamine pathways: implications for understanding obesity.The use of sibutramine in the management of obesity and related disorders: an update.Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity.Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implicationsEffect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Exploratory Literature Meta-Analysis to Characterize the Relationship Between Early and Longer Term Body Weight Loss for Antiobesity Compounds.Early weight loss and outcome at one year in obese adolescents treated with orlistat or placebo.
P2860
Q34995403-5904803B-B079-45C4-8C0B-B50D217383D4Q37202159-7E5B3979-8FA0-485C-A859-A9C10967BE88Q37337828-D86A13FD-7711-43CC-B68B-4E2E1CF39274Q37518344-4C19431D-AEAD-4838-BE00-6F3FFA4AEFD8Q37831911-06BC55B9-AC95-41AF-AF07-DE08A0DF061BQ38217456-3D339FB3-8146-4EC5-AF07-2E593ABE7938Q39699152-81D3785A-20AA-4F0E-A753-6291C1BE2450Q47413484-5D4784BB-3BED-4393-AE8A-FEB28326AEC9
P2860
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
@en
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
@nl
type
label
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
@en
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
@nl
prefLabel
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
@en
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
@nl
P2093
P2860
P50
P356
P1433
P1476
NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
@en
P2093
Aila M Rissannen
Bret Musser
Carol Addy
John M Amatruda
Joseph Proietto
Kaifeng Lu
Keith D Kaufman
Keith M Gottesdiener
Madhuja Mallick
P2860
P304
P356
10.1038/OBY.2007.242
P577
2007-08-01T00:00:00Z